Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Schizophrenia

Free Subscription 12.10.2026 1 Nat Genet 1 Pharmacopsychiatry 1 PLoS One 10 Psychiatry Res 1 Psychol Med 14 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Nat Genet

1. ZENG B, Yang H, N M P, Venkatesh S, et al
   Single-nucleus atlas of cell-type specific genetic regulation in the human brain.
   Nat Genet. 2026;58:2525-2534.
   PubMed         Abstract available
   
   

   
   Pharmacopsychiatry

2. KIM S, Lee KY, Chee HS, Choi J, et al
   Changes in Weight and Metabolic Indices after Switching to Aripiprazole Once-Monthly in Patients with Schizophrenia According to Prior Oral Antipsychotics.
   Pharmacopsychiatry. 2026 Oct 7. doi: 10.1055/a-2959-4334.
   PubMed         Abstract available
   
   

   
   PLoS One

3. ALLEN JD, Hong E, Choa FS
   Energy landscape and dynamic state modeling for schizophrenia biomarker extraction in task-based fMRI.
   PLoS One. 2026;21:e0339756.
   PubMed         Abstract available
   
   

   
   Psychiatry Res

4. LIVET A, Yunus FM, Nolwenn CG, Lecomte T, et al
   Group cognitive behavioral therapy for individuals on the early psychosis spectrum: a systematic review and a meta-analysis.
   Psychiatry Res. 2026;367:117502.
   PubMed         Abstract available
   
   
5. GALLO-ROITER D, Carneiro BA, Quarantini-Alvim Y, Argolo FC, et al
   Risk of schizophrenia in patients previously diagnosed with obsessive-compulsive disorder: a systematic review.
   Psychiatry Res. 2026;367:117486.
   PubMed         Abstract available
   
   
6. WANG YM, Chen F, Hou YW, Zhang M, et al
   Comparative efficacy of interventions for transdiagnostic anhedonia: a network meta-analysis.
   Psychiatry Res. 2026;366:117435.
   PubMed         Abstract available
   
   
7. NAYOK SB, Sreeraj VS, Nichenmetla S, Chhabra H, et al
   Gaze fixation stability is a transdiagnostic marker of major psychiatric disorders: A high-density family-based study.
   Psychiatry Res. 2026;366:117418.
   PubMed         Abstract available
   
   
8. PINGANI L, Lanzi N, De Marco E, Ferrazzi G, et al
   Algorithmic minds, human bias: How AI-generated images shape mental health stigma.
   Psychiatry Res. 2026;366:117450.
   PubMed         Abstract available
   
   
9. HERLITZIUS ER, Salahuddin NH, Siafis S, Leucht S, et al
   Psychological and psychosocial interventions for people with schizophrenia spectrum disorders and smoking addiction: A systematic review and pairwise meta-analysis.
   Psychiatry Res. 2026;367:117492.
   PubMed         Abstract available
   
   
10. YANG H, Luan L, Shi Z, Han Y, et al
    Plasma antioxidant enzyme imbalance in childhood- and adolescent-onset schizophrenia: clinical correlates and diagnostic utility.
    Psychiatry Res. 2026;367:117493.
    PubMed         Abstract available
    
    
11. GU C, Dang X, Yang X
    Multidimensional integrative analyses identify CA4 as a potential schizophrenia driver gene.
    Psychiatry Res. 2026;367:117484.
    PubMed         Abstract available
    
    
12. ABOU-RAHAL S, Tatar O, Abdel-Baki A, Coronado-Montoya S, et al
    Expanding the toolbox of interventions for cannabis use disorder in individuals with first-episode psychosis: A pilot randomized controlled trial of iCanChange (iCC), a novel app-based psychological intervention.
    Psychiatry Res. 2026;367:117476.
    PubMed         Abstract available
    
    
13. SUZUKI Y, Endo K, Yokokawa S, Watanabe K, et al
    Plasma interleukin-6 levels and treatment responses to antipsychotics in schizophrenia: Focus on clozapine treatment.
    Psychiatry Res. 2026;367:117487.
    PubMed         Abstract available
    
    

    
    Psychol Med

14. GUPTA Y, de la Cruz F, Geisler M, Rieger K, et al
    Accelerated brain aging as a transdiagnostic biomarker: A lifespan MRI brain age study across seven disorders.
    Psychol Med. 2026;56:e321.
    PubMed         Abstract available
    
    

    
    Schizophr Res

15. SAAD A, Montag C, Gillespie SM, Hadad BS, et al
    Age-associated differences in mentalizing error profiles in schizophrenia: Evidence for a dissociation between hypo- and hyper-mentalizing.
    Schizophr Res. 2026;298:96-103.
    PubMed         Abstract available
    
    
16. NELSON AM, Srinivasan A, Clementz B, Gershon E, et al
    Tobacco use moderates associations between cannabis use, psychiatric symptoms, and cognitive performance in psychosis spectrum disorders.
    Schizophr Res. 2026;298:88-95.
    PubMed         Abstract available
    
    
17. JIMENEZ E, Hinton W, Reeve S, Oduola S, et al
    Loneliness and socio-occupational functioning in psychosis: A systematic review.
    Schizophr Res. 2026;298:121-133.
    PubMed         Abstract available
    
    
18. STEINZ CA, Wahab RJ, Dielemans DAM, Wijnen BFM, et al
    Clinical and demographic characteristics associated with residual symptom severity in remitted first-episode psychosis.
    Schizophr Res. 2026;298:104-116.
    PubMed         Abstract available
    
    
19. STRAUSS GP, Raugh IM, Cowan T, Luther L, et al
    Toward the third generation of negative symptom assessment in schizophrenia: A systematic review of digital phenotyping measures.
    Schizophr Res. 2026;298:54-87.
    PubMed         Abstract available
    
    
20. PAPPA E, So C, McGowan J, Ng G, et al
    Command auditory verbal hallucinations in a culturally diverse early intervention in psychosis service: Prevalence, clinical associations and phenomenology.
    Schizophr Res. 2026;298:44-53.
    PubMed         Abstract available
    
    
21. VAN DER HEIJDEN H, Cao A, van Gool R, Yekeduz MK, et al
    Altered pain processing and associated neural circuitry disruptions in adolescents with early-onset psychosis.
    Schizophr Res. 2026;298:34-43.
    PubMed         Abstract available
    
    
22. CICOGNOLA C, Eratne D, Kang MJY, Janelidze S, et al
    Astrocytic activity in treatment-resistant and ultra-treatment-resistant schizophrenia.
    Schizophr Res. 2026;298:25-33.
    PubMed         Abstract available
    
    
23. DICKERSON F, Origoni A, Katsafanas E, Rowe K, et al
    Cigarette smoking trends among persons with psychiatric disorders: 1999-2026.
    Schizophr Res. 2026;297:472-478.
    PubMed         Abstract available
    
    
24. MARTIADIS V, Raffone F, Cervino A, Olivola M, et al
    Projected mortality impact of increasing second-generation long-acting injectable antipsychotic exposure in Italy: A scenario-based population model.
    Schizophr Res. 2026;297:445-453.
    PubMed         Abstract available
    
    
25. VAN DEN BUUSE M, Sbisa A, Gogos A
    Ovariectomy reverses maternal immune activation-induced deficits in dopamine and NMDA receptor-mediated regulation of prepulse inhibition in female Long-Evans rats.
    Schizophr Res. 2026;297:413-419.
    PubMed         Abstract available
    
    
26. BETZ GF, Vagedes H, Wehr S, Weigel L, et al
    Quality of Life Scale (QLS): A systematic review of measurement properties.
    Schizophr Res. 2026;297:375-383.
    PubMed         Abstract available
    
    
27. WHISKEY E, Oloyede E, Dzahini O, Aziri H, et al
    Off-licence use of clozapine: Lessons from an inner-city NHS trust - Comparison with other NHS Trusts.
    Schizophr Res. 2026;297:194-201.
    PubMed         Abstract available
    
    
28. BOKHARI SA, Elnoor M, Sabri M, Bardi M, et al
    Baseline neutrophil count, benign ethnic neutropenia risk, and clozapine haematological monitoring: A multi-ethnic retrospective cohort study from the United Arab Emirates.
    Schizophr Res. 2026;297:76-88.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum